Saturday, May 16, 2020 8:58:18 PM
It is not unseemly in the least. The AMRN shares lost 70% of their value, and $3.4 Billion of market cap due to her abject dereliction of judicial duty. Lives were destroyed.
If there is something nefarious or inappropriate that occurred, then at minimum, any aggrieved person can file a complaint against Judge Du on grounds of judicial misconduct or DISABILITY. (emphasis added).
https://www.ca9.uscourts.gov/content/view_jm.php?pk_id=0000000895
Above is the 9th Circuit link (Du is subject to jurisdiction of the 9th Circuit). The Complaint CANNOT just express sour grapes over her decision, while guessing what went on in the judge's mind.
However, a well-written, tailored complaint arguing that due to these circumstances, she was disabled, might, and I emphasize might, have merit.
I have not looked at the evidence that closely to opine with authority on the actual merits, but I can absolutely opine with uncertainty that exploring these issues and looking at the evidence, is neither unseemly nor devoid of merit. Indeed, the Ninth Circuit has a procedure in place for precisely exploring these issues.
I am going to review the evidence, and now having seen this available procedure, I might even consider filing the complaint myself, if there is enough merit to the underlying evidence. This cannot overturn what she has done, but may be a way of at least holding her accountable, and could even disqualify her from presiding over a successful appeal where the Federal Circuit remands back to the District Court.
If there is something nefarious or inappropriate that occurred, then at minimum, any aggrieved person can file a complaint against Judge Du on grounds of judicial misconduct or DISABILITY. (emphasis added).
https://www.ca9.uscourts.gov/content/view_jm.php?pk_id=0000000895
Above is the 9th Circuit link (Du is subject to jurisdiction of the 9th Circuit). The Complaint CANNOT just express sour grapes over her decision, while guessing what went on in the judge's mind.
However, a well-written, tailored complaint arguing that due to these circumstances, she was disabled, might, and I emphasize might, have merit.
I have not looked at the evidence that closely to opine with authority on the actual merits, but I can absolutely opine with uncertainty that exploring these issues and looking at the evidence, is neither unseemly nor devoid of merit. Indeed, the Ninth Circuit has a procedure in place for precisely exploring these issues.
I am going to review the evidence, and now having seen this available procedure, I might even consider filing the complaint myself, if there is enough merit to the underlying evidence. This cannot overturn what she has done, but may be a way of at least holding her accountable, and could even disqualify her from presiding over a successful appeal where the Federal Circuit remands back to the District Court.
Recent AMRN News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:02 PM
- Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 • GlobeNewswire Inc. • 04/15/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2026 09:01:34 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 09:00:20 PM
- American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:30:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/30/2026 09:57:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 09:00:07 PM
- Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline • GlobeNewswire Inc. • 03/18/2026 12:30:00 PM
- New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scienti • GlobeNewswire Inc. • 03/16/2026 12:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 10:31:01 PM
- Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:05:26 PM
- Amarin Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 02/25/2026 12:00:00 PM
- This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease • GlobeNewswire Inc. • 02/23/2026 01:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 25, 2026 • GlobeNewswire Inc. • 02/11/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 12:00:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 12:00:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 12:00:06 AM
